Director dealings: Creo Medical board members add to holdings

By

Sharecast News | 27 May, 2022

Creo Medical Group had several entries on the list of director buys on Friday, after it disclosed three share purchases made by two of its board members.

The AIM-traded firm said non-executive chairman Charles Spicer purchased 15,435 shares at a price of 97.18p each, spending a total of £14,999.73.

Following the transaction, Spicer's total direct interest in the company held via his self-invested personal pension was now 143,411 shares, representing 0.08% of its issued capital.

Chief financial officer Richard Rees, meanwhile, purchased a total of 70,000 shares at a price of 96.75p apiece.

It said Rees purchased 21,400 of those into his self-invested pension plan, for a total of £20,704.50, while the remaining 48,600 were purchased for a total value of £47,020.50.

Creo said Rees' total direct interest in the company was now 73,615 shares, representing 0.04% of its issued capital.

Reporting by Josh White at Sharecast.com.

Top Director Buys

I3 Energy (I3E)
Director name: Festival,John
Amount purchased: 354,500 @ $0.44
Value: $91,230.90

Surface Transforms (SCE)
Director name: Cleminson,Ian
Amount purchased: 102,053 @ 49.00p
Value: £50,005.97

Bakkavor Group (BAKK)
Director name: Lodge ,Jane Ann
Amount purchased: 50,000 @ 100.00p
Value: £50,000.00

Smithson Investment Trust (SSON)
Director name: Bartlett,Diana Dyer
Amount purchased: 3,886 @ 1,280.00p
Value: £49,740.80

Creo Medical Group (CREO)
Director name: Rees,Richard John
Amount purchased: 48,600 @ 96.75p
Value: £47,020.50

Creo Medical Group (CREO)
Director name: Rees,Richard John
Amount purchased: 21,400 @ 96.75p
Value: £20,704.50

Creo Medical Group (CREO)
Director name: Spicer,Charles
Amount purchased: 15,435 @ 97.18p
Value: £14,999.73

Last news